BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29446444)

  • 1. Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
    Worel N; Lehner E; Führer H; Kalhs P; Rabitsch W; Mitterbauer M; Hopfinger G; Greinix HT
    Transfusion; 2018 Apr; 58(4):1045-1053. PubMed ID: 29446444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease.
    Oarbeascoa G; Lozano ML; Guerra LM; Amunarriz C; Saavedra CA; Garcia-Gala JM; Viejo A; Revilla N; Acosta Fleitas C; Arroyo JL; Martinez Revuelta E; Galego A; Hernandez-Maraver D; Kwon M; Diez-Martin JL; Pascual C;
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):651-658. PubMed ID: 31917270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
    Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
    Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
    Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
    Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
    Liu C; Shah K; Dynis M; Eby CS; Grossman BJ
    Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
    Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
    Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Ussowicz M; Musiał J; Mielcarek M; Tomaszewska A; Nasiłowska-Adamska B; Kałwak K; Gorczyńska E; Mariańska B; Chybicka A
    Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.
    Berger M; Albiani R; Sini B; Fagioli F
    Transfusion; 2015 Apr; 55(4):736-47. PubMed ID: 25355659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience.
    Calore E; Marson P; Pillon M; Tumino M; Tison T; Mainardi C; De Silvestro G; Rossin S; Franceschetto G; Carraro E; Pescarin M; Varotto S; Destro R; Gazzola MV; Basso G; Messina C
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1963-72. PubMed ID: 26183078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease.
    Kitko CL; Abdel-Azim H; Carpenter PA; Dalle JH; Diaz-de-Heredia C; Gaspari S; Gennery AR; Handgretinger R; Lawitschka A
    Transplant Cell Ther; 2022 May; 28(5):261.e1-261.e7. PubMed ID: 35124293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience.
    Batgi H; Dal MS; Erkurt MA; Kuku I; Kurtoglu E; Hindilerden IY; Kaya E; Berber I; Ulas T; Altuntas F
    Transfus Apher Sci; 2021 Oct; 60(5):103242. PubMed ID: 34420882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of steroid-refractory chronic graft-versus-host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles.
    Bertani G; Santoleri L; Ferri U; Marenco P; Grillo G; Zucchetti E; Forno B; Lando G; Scarpati B; Cairoli R; Rossini S; Cesana C
    Transfusion; 2016 Feb; 56(2):505-10. PubMed ID: 26453579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
    Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
    J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shaping of CD56
    Ni M; Wang L; Yang M; Neuber B; Sellner L; Hückelhoven-Krauss A; Schubert ML; Luft T; Hegenbart U; Schönland S; Wuchter P; Chen BA; Eckstein V; Krüger W; Yerushalmi R; Beider K; Nagler A; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
    Front Immunol; 2019; 10():547. PubMed ID: 30949182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
    Alsuliman T; Magro L; Coiteux V; Gauthier J; Srour M; Lionet A; Beauvais D; Yakoub-Agha I
    Curr Res Transl Med; 2020 Apr; 68(2):71-76. PubMed ID: 31631014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a single-center experience.
    Niittyvuopio R; Juvonen E; Heiskanen J; Lindström V; Nihtinen A; Sahlstedt L; Volin L
    Transfusion; 2018 Aug; 58(8):1973-1979. PubMed ID: 29707788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.
    Jagasia M; Greinix H; Robin M; Das-Gupta E; Jacobs R; Savani BN; Engelhardt BG; Kassim A; Worel N; Knobler R; Russell N; Socie G
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1129-33. PubMed ID: 23623892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
    Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of extracorporeal photopheresis in pediatric patients with graft-versus-host disease after hematopoietic stem cell transplantation.
    Winther-Jørgensen S; Nygaard M; Heilmann C; Ifversen M; Sørensen K; Müller K; Masmas T
    Pediatr Transplant; 2019 Jun; 23(4):e13416. PubMed ID: 30973668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD).
    Solh MM; Farnham C; Solomon SR; Bashey A; Morris LE; Holland HK; Zhang X
    Bone Marrow Transplant; 2023 Feb; 58(2):168-174. PubMed ID: 36352015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.